Cargando…
Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris
Candida auris is an emerging global public health threat. It is an opportunistic yeast that usually affects critically ill patients in healthcare settings and is characterized by reduced susceptibility to multiple antifungal classes. Combination therapy with antifungals and repurposed drugs is a fea...
Autores principales: | Alanís-Ríos, Sergio A., González, Gloria M., Andrade, Angel, Becerril-García, Miguel A., Bonifaz, Alexandro, Robledo-Leal, Efrén R., Montoya, Alexandra M., Treviño-Rangel, Rogelio de J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421114/ https://www.ncbi.nlm.nih.gov/pubmed/36036298 http://dx.doi.org/10.1007/s42770-022-00817-y |
Ejemplares similares
-
Antifungal Resistance in Candida auris: Molecular Determinants
por: Frías-De-León, María Guadalupe, et al.
Publicado: (2020) -
Recent Antifungal Pipeline Developments against Candida auris: A Systematic Review
por: Treviño-Rangel, Rogelio de J., et al.
Publicado: (2022) -
In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades
por: Adnan, Awid, et al.
Publicado: (2023) -
A Case of Endogenous Trichosporon Endophthalmitis Treated with Micafungin and Voriconazole
por: Walia, Harpreet, et al.
Publicado: (2009) -
Identification and Elimination of Antifungal Tolerance in Candida auris
por: Rasouli Koohi, Samira, et al.
Publicado: (2023)